Key Takeaways
- • Morgan Stanley analyst Michael Cyprys cut Ares Management's (ARES) price target by $15 to $163 per share while maintaining an "Equal Weight" rating as of April 21, 2026.
- • The $163 price target represents the highest recent target among major banks, implying approximately 35.45% upside from recent levels on an equal-weight basis.
- • Despite Morgan Stanley's hold rating, the broader analyst consensus views Ares Management more favorably, with FactSet-polled analysts assigning an average "Overweight" rating and mean price target of $148.41.
- • Cyprys has demonstrated a 50% win rate over the past year with an average return of 2.5% across his ratings, according to TipRanks data.
Summary
Morgan Stanley analyst Michael Cyprys revised downward his price target on Ares Management (ARES) on April 21, 2026, lowering the valuation from $178 to $163 per share while reaffirming an "Equal Weight" rating on the alternative asset manager. The $15 reduction in the 12-month target price reflects a more cautious stance on the firm's near-term prospects, though the revised target remains the highest among major institutional research teams covering the name.
Notably, Cyprys's hold rating contrasts with the broader Street consensus on Ares Management. According to FactSet data on analyst sentiment, the average rating across surveyed analysts is "Overweight," with a consensus mean price target of $148.41 per share—approximately $14.59 below Morgan Stanley's revised target. This divergence suggests material disagreement among institutional analysts regarding valuation and near-term catalysts for the alternative investment manager.
From a track record perspective, Cyprys maintains a 50% success rate on his recommendations over the trailing 12 months, generating an average return of 2.5% across his rated universe, according to TipRanks' analyst scoring methodology. This performance metric suggests mixed historical accuracy in his stock selection and timing, warranting consideration alongside the fundamental rationale for the downgrade.
The downward revision likely reflects evolving views on Ares Management's asset growth trajectory, fee compression pressures within the alternatives industry, or macroeconomic headwinds affecting investor demand for alternative strategies. Institutional investors and hedge fund managers should reconcile Morgan Stanley's cautious stance with the more constructive consensus view when reassessing their positioning in the name.
Notably, Cyprys's hold rating contrasts with the broader Street consensus on Ares Management. According to FactSet data on analyst sentiment, the average rating across surveyed analysts is "Overweight," with a consensus mean price target of $148.41 per share—approximately $14.59 below Morgan Stanley's revised target. This divergence suggests material disagreement among institutional analysts regarding valuation and near-term catalysts for the alternative investment manager.
From a track record perspective, Cyprys maintains a 50% success rate on his recommendations over the trailing 12 months, generating an average return of 2.5% across his rated universe, according to TipRanks' analyst scoring methodology. This performance metric suggests mixed historical accuracy in his stock selection and timing, warranting consideration alongside the fundamental rationale for the downgrade.
The downward revision likely reflects evolving views on Ares Management's asset growth trajectory, fee compression pressures within the alternatives industry, or macroeconomic headwinds affecting investor demand for alternative strategies. Institutional investors and hedge fund managers should reconcile Morgan Stanley's cautious stance with the more constructive consensus view when reassessing their positioning in the name.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.